Ans: Continuous bioprocessing can be defined as the segment of the biopharmaceutical industry that focuses on the production and manufacturing of biologics, vaccines, and pharmaceuticals using continuous and uninterrupted processes, which are opposite to traditional batch processing. This market includes bioreactors, chromatography systems, consumables, filtration systems and devices, and other related products involved in the streamlined and continuous production of biopharmaceutical products such as monoclonal antibodies, vaccines, cell and gene therapy and other applications, with the aim of improving efficiency, reducing production costs, and accelerating the delivery of vital medical treatments to patients.
Read More